Back

Hyperkalemia incidence and recurrence among patients with heart failure - predictors and temporal trends

10 May 2026 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Navigating the cardio-renal syndrome (2) Comorbidities HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Felix Lindberg

Karolinska Institute, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
Predicting diuretic resistance without urine output in acute heart failure
Mrs E. Vice (Atlanta, US)
Abstract Slides Video
Presentation thumbnail
Renal safety of a natriuresis-guided diuretic strategy in hospitalised heart failure
Doctor S. Singh (Hartford, US)
Abstract Slides Video
Presentation thumbnail
Thiazides attenuate the diuretic response to pecavaptan, a dual vasopressin receptor antagonist, in hospitalized heart failure patients
Doctor D. Ceelen (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Sustained low-efficiency dialysis for refractory congestion in advanced cardiorenal syndrome: haemodyamics and weight reduction analysis
Doctor G. Mihelcic (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Navigating the cardio-renal syndrome (2)

The Event

Event poster

Heart Failure 2026

10 May 2026 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Hyperkalemia events in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan or sodium-glucose transport protein 2 inhibitors: a single-center experience
thumbnail
Congress Presentation
Challenges of managing hyperkalaemia in HF patients with CKD while maintaining RAAS inhibitor therapy
thumbnail
Congress Presentation
Prognostic value of hyperkalemia and mineralocorticoid receptor antagonist use in heart failure: a national registry study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources